Literature DB >> 33415093

Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors.

Om Prakash1, Fokhrul Hossain1, Denise Danos1, Adam Lassak1, Richard Scribner2, Lucio Miele1.   

Abstract

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2). TNBC constitutes about 15-30 percent of all diagnosed invasive breast cancer cases in the United States. African-American (AA) women have high prevalence of TNBC with worse clinical outcomes than European-American (EA) women. The contributing factors underlying racial disparities have been divided into two major categories based on whether they are related to lifestyle (non-biologic) or unrelated to lifestyle (biologic). Our objective in the present review article was to understand the potential interactions by which these risk factors intersect to drive the initiation and development of the disparities resulting in the aggressive TNBC subtypes in AA women more likely than in EA women. To reach our goal, we conducted literature searches using MEDLINE/PubMed to identify relevant articles published from 2005 to 2019 addressing breast cancer disparities primarily among AA and EA women in the United States. We found that disparities in TNBC may be attributed to racial differences in biological factors, such as tumor heterogeneity, population genetics, somatic genomic mutations, and increased expression of genes in AA breast tumors which have direct link to breast cancer. In addition, a large number of non-biologic factors, including socioeconomic deprivation adversities associated with poverty, social stress, unsafe neighborhoods, lack of healthcare access and pattern of reproductive factors, can promote comorbid diseases such as obesity and diabetes which may adversely contribute to the aggression of TNBC biology in AA women. Further, the biological risk factors directly linked to TNBC in AA women may potentially interact with non-biologic factors to promote a higher prevalence of TNBC, more aggressive biology, and poor survival. The relative contributions of the biologic and non-biologic factors and their potential interactions is essential to our understanding of disproportionately high burden and poor survival rates of AA women with TNBC.
Copyright © 2020 Prakash, Hossain, Danos, Lassak, Scribner and Miele.

Entities:  

Keywords:  African-American women; body mass index; non-hispanic whites; obesity; racial disparities; socioeconomic status; triple negative breast cancer; waist-hip ratio

Year:  2020        PMID: 33415093      PMCID: PMC7783321          DOI: 10.3389/fpubh.2020.576964

Source DB:  PubMed          Journal:  Front Public Health        ISSN: 2296-2565


  147 in total

Review 1.  Epidemiology, biology, and treatment of triple-negative breast cancer in women of African ancestry.

Authors:  Abenaa M Brewster; Mariana Chavez-MacGregor; Powel Brown
Journal:  Lancet Oncol       Date:  2014-11-24       Impact factor: 41.316

Review 2.  Obesity and Triple-Negative Breast Cancer: Disparities, Controversies, and Biology.

Authors:  Eric C Dietze; Tanya A Chavez; Victoria L Seewaldt
Journal:  Am J Pathol       Date:  2017-11-09       Impact factor: 4.307

3.  Impact of race and ethnicity on outcomes for estrogen receptor-negative breast cancers: experience of an academic center with a charity hospital.

Authors:  Quyen D Chu; Gary Burton; Jonathan Glass; Mark H Smith; Benjamin D L Li
Journal:  J Am Coll Surg       Date:  2010-05       Impact factor: 6.113

4.  Triple-negative breast carcinoma in African American and Caucasian women: clinicopathology, immunomarkers, and outcome.

Authors:  Harold C Sullivan; Gabriela Oprea-Ilies; Amy L Adams; Andrew J Page; Sungjin Kim; Jason Wang; Cynthia Cohen
Journal:  Appl Immunohistochem Mol Morphol       Date:  2014-01

5.  Triple-negative breast cancer and obesity in a rural Appalachian population.

Authors:  Linda Vona-Davis; David P Rose; Hannah Hazard; Marissa Howard-McNatt; Farrell Adkins; Jessica Partin; Gerald Hobbs
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-12       Impact factor: 4.254

6.  How basal are triple-negative breast cancers?

Authors:  François Bertucci; Pascal Finetti; Nathalie Cervera; Benjamin Esterni; Fabienne Hermitte; Patrice Viens; Daniel Birnbaum
Journal:  Int J Cancer       Date:  2008-07-01       Impact factor: 7.396

7.  Outcome for patients with triple-negative breast cancer is not dependent on race/ethnicity.

Authors:  Quyen D Chu; Amanda E Henderson; Fred Ampil; Benjamin D L Li
Journal:  Int J Breast Cancer       Date:  2012-05-08

8.  Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database.

Authors:  Magdalena L Plasilova; Brandon Hayse; Brigid K Killelea; Nina R Horowitz; Anees B Chagpar; Donald R Lannin
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

9.  Differences in the tumor microenvironment between African-American and European-American breast cancer patients.

Authors:  Damali N Martin; Brenda J Boersma; Ming Yi; Mark Reimers; Tiffany M Howe; Harry G Yfantis; Yien Che Tsai; Erica H Williams; Dong H Lee; Robert M Stephens; Allan M Weissman; Stefan Ambs
Journal:  PLoS One       Date:  2009-02-19       Impact factor: 3.240

10.  Elevated Resistin Gene Expression in African American Estrogen and Progesterone Receptor Negative Breast Cancer.

Authors:  Karin A Vallega; NingNing Liu; Jennifer S Myers; Kaixian Yu; Qing-Xiang Amy Sang
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

View more
  20 in total

1.  Are there differences in outcomes by race among women with metastatic triple-negative breast cancer?

Authors:  Bridget A Oppong; Angel A Rolle; Amara Ndumele; Yaming Li; James L Fisher; Oindrila Bhattacharyya; Toyin Adeyanju; Electra D Paskett
Journal:  Breast Cancer Res Treat       Date:  2022-09-24       Impact factor: 4.624

2.  Thymoquinone Alterations of the Apoptotic Gene Expressions and Cell Cycle Arrest in Genetically Distinct Triple-Negative Breast Cancer Cells.

Authors:  Getinet M Adinew; Samia S Messeha; Equar Taka; Ramesh B Badisa; Lovely M Antonie; Karam F A Soliman
Journal:  Nutrients       Date:  2022-05-19       Impact factor: 6.706

3.  Multifunctional Lipid Bilayer Nanocarriers for Cancer Immunotherapy in Heterogeneous Tumor Microenvironments, Combining Immunogenic Cell Death Stimuli with Immune Modulatory Drugs.

Authors:  André E Nel; Kuo-Ching Mei; Yu-Pei Liao; Xiangsheng Liu
Journal:  ACS Nano       Date:  2022-03-29       Impact factor: 18.027

4.  Patient-Derived Triple-Negative Breast Cancer Organoids Provide Robust Model Systems That Recapitulate Tumor Intrinsic Characteristics.

Authors:  Melissa Kramer; Suzanne Russo; Payal Naik; Sonam Bhatia; Gayatri Arun; Kyle Brophy; Peter Andrews; Cheng Fan; Charles M Perou; Jonathan Preall; Taehoon Ha; Dennis Plenker; David A Tuveson; Arvind Rishi; John E Wilkinson; W Richard McCombie; Karen Kostroff; David L Spector
Journal:  Cancer Res       Date:  2022-04-01       Impact factor: 13.312

5.  Common founder BRCA2 pathogenic variants and breast cancer characteristics in Ethiopian Jews.

Authors:  S Lieberman; R Chen-Shtoyerman; Z Levi; S Shkedi-Rafid; S Zuckerman; R Bernstein-Molho; G Reznick Levi; S S Shachar; A Flugelman; V Libman; I Kedar; S Naftaly-Nathan; I Lagovsky; T Peretz; N Karminsky; S Carmi; E Levy-Lahad; Y Goldberg
Journal:  Breast Cancer Res Treat       Date:  2022-03-12       Impact factor: 4.624

6.  Obesity Modulates the Gut Microbiome in Triple-Negative Breast Cancer.

Authors:  Fokhrul Hossain; Samarpan Majumder; Justin David; Bruce A Bunnell; Lucio Miele
Journal:  Nutrients       Date:  2021-10-19       Impact factor: 5.717

7.  Breast Cancer in the Elderly: An Observational Study Investigating Compliance of Screening Mammography in an Underserved Community.

Authors:  Shruti Sharma; Dixita Patel; Sushma Pavuluri; Amy Stein; Binal Patel; Nadia Qureshi; Imran Hasnuddin; Tsvetelina Todorova; Krishnan Srinivasan; Masood Ghouse
Journal:  World J Oncol       Date:  2021-10-21

Review 8.  Roles of Protein Disulfide Isomerase in Breast Cancer.

Authors:  Suhui Yang; Chanel Jackson; Eduard Karapetyan; Pranabananda Dutta; Dulcie Kermah; Yong Wu; Yanyuan Wu; John Schloss; Jaydutt V Vadgama
Journal:  Cancers (Basel)       Date:  2022-01-31       Impact factor: 6.639

9.  Risk factors for breast cancer subtypes among Black women undergoing screening mammography.

Authors:  Tara M Friebel-Klingner; Sarah Ehsan; Emily F Conant; Despina Kontos; Susan M Domchek; Anne Marie McCarthy
Journal:  Breast Cancer Res Treat       Date:  2021-08-03       Impact factor: 4.872

10.  Investigation of the Effects and Mechanisms of Anticancer Action of a Ru(II)-Arene Iminophosphorane Compound in Triple Negative Breast Cancer Cells.

Authors:  Nazia Nayeem; Arefa Yeasmin; Samantha N Cobos; Ali Younes; Karen Hubbard; Maria Contel
Journal:  ChemMedChem       Date:  2021-08-24       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.